Literature DB >> 29568001

Dysosteosclerosis is also caused by TNFRSF11A mutation.

Long Guo1, Nursel H Elcioglu2,3, Ozge K Karalar2, Mert O Topkar4, Zheng Wang1,5, Yuma Sakamoto, Naomichi Matsumoto6, Noriko Miyake6, Gen Nishimura7, Shiro Ikegawa8.   

Abstract

Dysosteosclerosis (DOS) is a form of sclerosing bone disease characterized by irregular osteosclerosis and platyspondyly. Its mode of inheritance is autosomal recessive. SLC29A3 mutations have been reported as the causal gene in two DOS families, however, genetic heterogeneity has been suggested. By whole-exome sequencing in a Turkish patient with DOS, we found a novel splice-site mutation in TNFRSF11A. TNFRSF11A mutations have previously been reported in two autosomal dominant diseases (osteolysis, familial expansile and Paget disease of bone 2, early-onset) and an autosomal recessive disease (osteopetrosis, autosomal recessive 7). The biallelic mutation, c.616+3A>G, identified in our study was located in the splice donor site of intron 6 of TNFRSF11A. Exon trapping assay indicated the mutation caused skipping of exon 6, which was predicted to induce a frame-shift and an early termination codon in all known alternative transcript variants of TNFRSF11A. The predicted effect of the mutation for the isoforms was different from those of the previously reported mutations, which could explain the difference of their phenotypes. Thus, our study identified the second disease gene for DOS. TNFRSF11A isoforms may have the different roles in skeletal development and metabolism.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29568001     DOI: 10.1038/s10038-018-0447-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  23 in total

1.  Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.

Authors:  A E Hughes; S H Ralston; J Marken; C Bell; H MacPherson; R G Wallace; W van Hul; M P Whyte; K Nakatsuka; L Hovy; D M Anderson
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

2.  Expanding the clinical spectrum of SLC29A3 gene defects.

Authors:  Ronen Spiegel; Simon T Cliffe; Michael F Buckley; Yanick J Crow; Jill Urquhart; Yoseph Horovitz; Yardena Tenenbaum-Rakover; William G Newman; Dian Donnai; Stavit A Shalev
Journal:  Eur J Med Genet       Date:  2010-07-07       Impact factor: 2.708

3.  Atypical giant axonal neuropathy arising from a homozygous mutation by uniparental isodisomy.

Authors:  S Miyatake; H Tada; S Moriya; J Takanashi; Y Hirano; M Hayashi; Y Oya; M Nakashima; Y Tsurusaki; N Miyake; N Matsumoto; H Saitsu
Journal:  Clin Genet       Date:  2014-09-08       Impact factor: 4.438

4.  Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.

Authors:  Philippe M Campeau; James T Lu; Gautam Sule; Ming-Ming Jiang; Yangjin Bae; Simran Madan; Wolfgang Högler; Nicholas J Shaw; Steven Mumm; Richard A Gibbs; Michael P Whyte; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2012-08-08       Impact factor: 6.150

5.  Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis.

Authors:  Chia-Lin Hsu; Weiyu Lin; Dhaya Seshasayee; Yung-Hsiang Chen; Xiao Ding; Zhonghua Lin; Eric Suto; Zhiyu Huang; Wyne P Lee; Hyunjoo Park; Min Xu; Mei Sun; Linda Rangell; Jeff L Lutman; Sheila Ulufatu; Eric Stefanich; Cecile Chalouni; Meredith Sagolla; Lauri Diehl; Paul Fielder; Brian Dean; Mercedesz Balazs; Flavius Martin
Journal:  Science       Date:  2011-12-15       Impact factor: 47.728

6.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

7.  Identification of a novel LRRK1 mutation in a family with osteosclerotic metaphyseal dysplasia.

Authors:  Long Guo; Katta M Girisha; Aritoshi Iida; Malavika Hebbar; Anju Shukla; Hitesh Shah; Gen Nishimura; Naomichi Matsumoto; Shifa Nismath; Noriko Miyake; Shiro Ikegawa
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

Review 8.  Dysosteosclerosis presents as an "osteoclast-poor" form of osteopetrosis: comprehensive investigation of a 3-year-old girl and literature review.

Authors:  Michael P Whyte; Deborah Wenkert; William H McAlister; Deborah V Novack; Angie R Nenninger; Xiafang Zhang; Margaret Huskey; Steven Mumm
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

9.  Identification of biallelic EXTL3 mutations in a novel type of spondylo-epi-metaphyseal dysplasia.

Authors:  Long Guo; Nursel H Elcioglu; Shuji Mizumoto; Zheng Wang; Bilge Noyan; Hatice M Albayrak; Shuhei Yamada; Naomichi Matsumoto; Noriko Miyake; Gen Nishimura; Shiro Ikegawa
Journal:  J Hum Genet       Date:  2017-03-23       Impact factor: 3.172

10.  Novel and recurrent COL11A1 and COL2A1 mutations in the Marshall-Stickler syndrome spectrum.

Authors:  Long Guo; Nursel H Elcioglu; Zheng Wang; Yasemin K Demirkol; Pinar Isguven; Naomichi Matsumoto; Gen Nishimura; Noriko Miyake; Shiro Ikegawa
Journal:  Hum Genome Var       Date:  2017-10-05
View more
  6 in total

1.  Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation.

Authors:  Long Guo; Débora Romeo Bertola; Asako Takanohashi; Asuka Saito; Yuko Segawa; Takanori Yokota; Satoru Ishibashi; Yoichiro Nishida; Guilherme Lopes Yamamoto; José Francisco da Silva Franco; Rachel Sayuri Honjo; Chong Ae Kim; Camila Manso Musso; Margaret Timmons; Amy Pizzino; Ryan J Taft; Bryan Lajoie; Melanie A Knight; Kenneth H Fischbeck; Andrew B Singleton; Carlos R Ferreira; Zheng Wang; Li Yan; James Y Garbern; Pelin O Simsek-Kiper; Hirofumi Ohashi; Pamela G Robey; Alan Boyde; Naomichi Matsumoto; Noriko Miyake; Jürgen Spranger; Raphael Schiffmann; Adeline Vanderver; Gen Nishimura; Maria Rita Dos Santos Passos-Bueno; Cas Simons; Kinya Ishikawa; Shiro Ikegawa
Journal:  Am J Hum Genet       Date:  2019-04-11       Impact factor: 11.025

2.  Identification of Prognostic Immune-Related Genes by Integrating mRNA Expression and Methylation in Lung Adenocarcinoma.

Authors:  Jie Zhu; Min Wang; Daixing Hu
Journal:  Int J Genomics       Date:  2020-07-09       Impact factor: 2.326

Review 3.  One Disease, Many Genes: Implications for the Treatment of Osteopetroses.

Authors:  Sara Penna; Valentina Capo; Eleonora Palagano; Cristina Sobacchi; Anna Villa
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-19       Impact factor: 5.555

4.  Deficiency of TMEM53 causes a previously unknown sclerosing bone disorder by dysregulation of BMP-SMAD signaling.

Authors:  Long Guo; Aritoshi Iida; Gandham SriLakshmi Bhavani; Kalpana Gowrishankar; Zheng Wang; Jing-Yi Xue; Juan Wang; Noriko Miyake; Naomichi Matsumoto; Takanori Hasegawa; Yusuke Iizuka; Masashi Matsuda; Tomoki Nakashima; Masaki Takechi; Sachiko Iseki; Shinsei Yambe; Gen Nishimura; Haruhiko Koseki; Chisa Shukunami; Katta M Girisha; Shiro Ikegawa
Journal:  Nat Commun       Date:  2021-04-06       Impact factor: 14.919

5.  A Null Mutation of TNFRSF11A Causes Dysosteosclerosis, Not Osteopetrosis.

Authors:  Tarık Kırkgöz; Behzat Özkan; Filiz Hazan; Sezer Acar; Özlem Nalbantoğlu; Beyhan Özkaya; Melike Ataseven Kulalı; Semra Gürsoy; Shiro Ikegawa; Long Guo
Journal:  Front Genet       Date:  2022-06-24       Impact factor: 4.772

6.  Dysosteosclerosis: Clinical and Radiological Evolution Reflecting Genetic Heterogeneity.

Authors:  Serap Turan; Steven Mumm; Ceren Alavanda; Betul Sare Kaygusuz; Busra Gurpinar Tosun; Ahmet Arman; Margaret Huskey; Tulay Guran; Shenghui Duan; Abdullah Bereket; Michael P Whyte
Journal:  JBMR Plus       Date:  2022-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.